Bicara Therapeutics (BCAX)
Developing a bifunctional antibody program for head and neck and other solid tumors.
$21.41
vs last close−1.37 (−6.01%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 47 days
EPS estimate
−$0.85
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.39−$0.68−$0.50−$0.67−$0.68−$0.93−$0.82Pending
Estimate−$0.31−$0.40−$0.54−$0.55−$0.72−$0.64−$0.82−$0.85
Surprise−25.8%−70.0%+7.4%−21.8%+5.6%−45.3%0.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$1.02 | — | — |
| Sep 2027 | −$0.87 | — | — |
| Jun 2027 | −$0.90 | — | — |
| Mar 2027 | −$0.95 | — | — |
| Dec 2026 | −$0.86 | — | — |
| Nov 2026 | −$0.85 | — | — |
| Aug 2026 | −$0.82 | −$0.82 | 0.0% |
| May 2026 | −$0.64 | −$0.93 | −45.3% |
| Mar 2026 | −$0.72 | −$0.68 | +5.6% |
| Nov 2025 | −$0.55 | −$0.67 | −21.8% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| Jun 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$1.02 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.87 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.90 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.95 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.86 | — | — | $0 | — | — | — |
| Nov 9, 2026 | −$0.85 | — | — | $0 | — | — | — |
| Aug 11, 2026 | −$0.82 | −$0.82 | 0.0% | — | — | — | −14.3% |
| May 11, 2026 | −$0.64 | −$0.93 | −45.3% | — | — | — | +1.5% |
| Mar 26, 2026 | −$0.72 | −$0.68 | +5.6% | — | — | — | +1.3% |
| Nov 10, 2025 | −$0.55 | −$0.67 | −21.8% | — | — | — | −4.9% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Sep 13, 2024 | |||||||
| Jun 30, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 |